LAVA Therapeutics N.V. (LVTX)
$1.74+0.00%Close
BUYBULL · day 27
Key stats
- Market cap
- $46M
- Avg volume
- 346.6K
- Beta
- 0.50
- P/E (TTM)
- -2.42
- 1W
- +0.00%
- 1M
- +8.07%
- 3M
- +10.83%
- YTD
- +15.23%
- vs SPY 1W
- +1.19%
- vs SPY 1M
- +4.75%
- vs SPY 3M
- +8.44%
- vs SPY YTD
- +3.48%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ICCMSELLIceCure Medical LtdCRISISQ -19$2.27-6.58%
- GNPXSELLGenprex, Inc.CRISISQ -20$4.02+1.77%
- ADILBUYAdial Pharmaceuticals, Inc.RECOVERYQ -14$5.40-13.18%
- VORBUYVor Biopharma Inc.RECOVERYQ -13$22.71-2.78%
- CELG-RIBUYBristol-Myers Squibb Company CeCRISISQ 8$0.10-16.67%
- NEUPBUYNeuphoria Therapeutics Inc.RECOVERYQ -13$3.95+1.02%
- KPRXBUYKiora Pharmaceuticals, Inc.RECOVERYQ -16$2.75+3.38%
- RXSTBUYRxSight, Inc.BEARQ -10$6.26+0.16%
- CLDISELLCalidi Biotherapeutics, Inc.CRISISQ -30$1.38+2.99%
- DWTXBUYDogwood Therapeutics, Inc.RECOVERYQ -13$2.56+2.81%
- EXOZBUYeXoZymes, Inc.RECOVERYQ 0$6.95-2.80%
- SEPNBUYSepterna, Inc.CRISISQ 29$40.52+1.30%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 12
- VALUE
- 18
- GROWTH
- 39
- GARP
- 2
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-59.5%
REV YoY-
ROE-99.2%
EPS YoY-
ROA-37.2%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-2.42
P/E FWD-
SECTOR PE22.57
INDUSTRY PE17.06
P/B3.69
P/FCF-
EV/EBITDA0.21
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO12.27
ND/EBITDA-
BETA0.50
Company news
Loading headlines…